IP Library Granted Patent US 8,545,829
Granted Patent B2
US 8,545,829 · App. 10/516,344 · Granted Oct 1, 2013

Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents

Inventors: Dirk Mertin (Langenfeld, DE); Markus Edingloh (Leverkusen, DE); Gert Daube (Engelskirchen, DE)
Assignee: Bayer Intellectual Property GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,545,829
App. No.
10/516,344
Granted
Oct 1, 2013
Kind
B2
Abstract

The present invention relates to pharmaceutical preparations for oral administration, comprising one or more active substances bound to an ion exchanger. In order to improve physical stability and acceptance, particularly in animals, a pseudoplastic gel-former thickener is included.

Claims (10)

1. A liquid pharmaceutical preparation comprising pradofloxacin bound to an ion exchange resin dispersed in a carrier medium comprising water and xanthan as a pseudoplastic gel former, wherein the concentration of xanthan in the preparation is from 0.3% to 0.7% by weight.

2. The pharmaceutical preparation according to claim 1 , wherein the ion exchange resin is an acidic ion exchanger.

3. The pharmaceutical preparation according to claim 1 , wherein the loading of ion exchange resin with pradofloxacin in the preparation is from 1% to 50% by weight, based on the total weight of the preparation.

4. The pharmaceutical preparation according to claim 1 , wherein the loading of ion exchange resin with pradofloxacin in the preparation is from 5% to 30% by weight, based on the total weight of the preparation.

5. The pharmaceutical preparation according to claim 1 , wherein the carrier medium is from 10 to 98% by weight of the total preparation.

6. The pharmaceutical preparation according to claim 1 , wherein the carrier medium is from 20% to 90% by weight of the total preparation.

7. The pharmaceutical preparation according to claim 1 , wherein the loading of ion exchange resin with pradofloxacin in the preparation is from 5% to 25% by weight, based on the total weight of the preparation.

8. The pharmaceutical preparation according to claim 1 , further comprising bentonite.

9. The pharmaceutical preparation according to claim 1 , wherein the concentration of xanthan in the preparation is from 0.5% to 0.7% by weight.

10. The pharmaceutical preparation according to claim 1 , wherein the concentration of xanthan in the preparation is about 0.7% by weight.

Assignments (5)
CHANGE OF NAME Recorded Feb 8, 2024
From: BAYER ANIMAL HEALTH GMBH
To: ELANCO ANIMAL HEALTH GMBH
Reel/Frame 066525/0898 →
NUNC PRO TUNC ASSIGNMENT Recorded Feb 7, 2024
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER ANIMAL HEALTH GMBH
Reel/Frame 066401/0955 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2013
From: BAYER ANIMAL HEALTH GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030127/0549 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2009
From: BAYER HEALTHCARE AG
To: BAYER ANIMAL HEALTH GMBH
Reel/Frame 022213/0726 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2005
From: MERTIN, DIRK; EDINGLOH, MARKUS; DAUBE, GERT
To: BAYER HEALTHCARE AG
Reel/Frame 017578/0542 →
Priority Claims (1)
DE 102 24 086 · May 31, 2002 · national
Continuity (1)
Related Publication 20060177414A1 · Aug 10, 2006